This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1985 Feb 16;1(8425):405-6.

doi: 10.1016/s0140-6736(85)91431-x.

Hepatitis B immune globulin to prevent non-A, non-B post-transfusion hepatitis

U Sugg, W Schneider, H E Hoffmeister, C Huth, W Stephan, R Lissner, W Haase

PMID: 2857461
DOI: 10.1016/s0140-6736(85)91431-x

Clinical Trial

Hepatitis B immune globulin to prevent non-A, non-B post-transfusion hepatitis

U Sugg et al. Lancet. 1985.

. 1985 Feb 16;1(8425):405-6.

doi: 10.1016/s0140-6736(85)91431-x.

Authors

U Sugg, W Schneider, H E Hoffmeister, C Huth, W Stephan, R Lissner, W Haase

PMID: 2857461
DOI: 10.1016/s0140-6736(85)91431-x

No abstract available

PubMed Disclaimer

Similar articles

Modern vaccines. Hepatitis.
Eddleston A. Eddleston A. Lancet. 1990 May 12;335(8698):1142-5. doi: 10.1016/0140-6736(90)91138-z. Lancet. 1990. PMID: 1971874 Review. No abstract available.
Viral hepatitis: update on prevention.
Alter MJ. Alter MJ. Henry Ford Hosp Med J. 1984;32(2):101-6. Henry Ford Hosp Med J. 1984. PMID: 6439691 Review. No abstract available.
Prevention of hepatitis.
Siegel JD. Siegel JD. Pediatr Infect Dis. 1985 Jul-Aug;4(4):434-9. doi: 10.1097/00006454-198507000-00050. Pediatr Infect Dis. 1985. PMID: 3927271 No abstract available.
[Incidence of infectious hepatitis in the Russian Federation and sociomedical measures to prevent its prevalence].
Onishchenko GG. Onishchenko GG. Vestn Ross Akad Med Nauk. 2001;(8):31-4. Vestn Ross Akad Med Nauk. 2001. PMID: 11552622 Russian. No abstract available.
Australia antigen and the prevention of posttransfusion hepatitis.
Blumberg BS. Blumberg BS. Vox Sang. 1985;48(1):55-9. doi: 10.1111/j.1423-0410.1985.tb00146.x. Vox Sang. 1985. PMID: 3881877 Review. No abstract available.

See all similar articles

Cited by

Neutralizing antibody response to hepatitis C virus.
Wang Y, Keck ZY, Foung SK. Wang Y, et al. Viruses. 2011 Nov;3(11):2127-45. doi: 10.3390/v3112127. Epub 2011 Nov 2. Viruses. 2011. PMID: 22163337 Free PMC article. Review.
Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view.
Abrignani S. Abrignani S. Springer Semin Immunopathol. 1997;19(1):47-55. doi: 10.1007/BF00945024. Springer Semin Immunopathol. 1997. PMID: 9266630 Review. No abstract available.
Human Immunoglobulins for intravenous use and hepatitis C viral transmission.
Slade HB. Slade HB. Clin Diagn Lab Immunol. 1994 Nov;1(6):613-9. doi: 10.1128/cdli.1.6.613-619.1994. Clin Diagn Lab Immunol. 1994. PMID: 8556510 Free PMC article. Review. No abstract available.
Transmission of diseases by blood transfusion.
Seidl S, Kühnl P. Seidl S, et al. World J Surg. 1987 Feb;11(1):30-5. doi: 10.1007/BF01658456. World J Surg. 1987. PMID: 3544518 Review. No abstract available.
Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.
Keck ZY, Li SH, Xia J, von Hahn T, Balfe P, McKeating JA, Witteveldt J, Patel AH, Alter H, Rice CM, Foung SK. Keck ZY, et al. J Virol. 2009 Jun;83(12):6149-60. doi: 10.1128/JVI.00248-09. Epub 2009 Mar 25. J Virol. 2009. PMID: 19321602 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information